chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arm is still weak; Tiredness; Headache; Muscle pain; Chills; Joint pain; Fever; Nausea; Feeling unwell; Little bit of pain from the injection site; This is a spontaneous report from a contactable consumer (patient). A 71-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL3249), via an unspecified route of administration, on 13Jan2021, at a single dose, for COVID-19 immunization. The patient's medical history included diabetes (controlled by food not by injection), coronary artery spasm (blood vessels that occasionally collapsed), glaucoma, and asthma. The patient's concomitant medications included albuterol for asthma, atorvastatin (LIPITOR), glyceryl trinitrate (NITROGLYCERIN) for coronary artery spasm, and numbers of eye drops (unspecified) for glaucoma. The patient had taken the COVID-19 vaccine just not too long ago and had good number of non-serious side effects. The patient was not really concerned with these side effects that she had. On 13Jan2021, the patient had the little bit of pain from the injection site but that's common with any injection, so he did not count it, but next day the events started, and he still had some, but they were subsiding. The next events happened the next day after administration (14Jan2021). The patient had the injection site pain and the arm is still weak, tiredness, headache, muscle pain, chills, joint pain, fever, nausea, and feeling unwell on 14Jan2021. The patient was recovering from the events.
Myalgia, Arthralgia, Fever,  chills, loss of taste, loss of appetite, injection site pain  Narrative:
It was reported that a 40 year old female received a Fluzone WV '99-'00 vaccination on 10/27/99. Reportedly, 24 hours, post vax, the pt developed an itchy rash over face, nick, chest and also at the injection site. The pt was seen by a physician.
40 year old lady with hx fibromyalgia, inflammatory polyarthritis, Sjogren syndrome, anxiety who was admitted on 5/26 when she collapsed and noted to have generalized convulsions, bit her tongue and brought to the hospital, found to have another generalized seizure. EEG showed numerous electrical seizures mainly from the right but from 5/28 , had left sided involvement too. She initially was started on Levetiracetam and then Lacosamide, Phenytoin and Valproic acid were addend. She had LP and CSF was unremarkable. CSF was send for autoimmune encephalitis /epilesy panel were negative. On 5/30 she started on Solumedrol 1 gr daily for 5 days for presumably autoimmune seizure. Seizures were improved. Last subclinical seizure was recorded on 6/3/21 around 5 am. Patient had brain MRI shoed slight increased signal in right mesiotemporl , hippocampus  region.   Of note she had Moderana Covid-19 vaccine around 3 weeks prior to presentation
Patient was given one manufacturer first dose and came to clinic front check in area asking for different manufacturer.  She and spouse came back to vaccination area asking for covid vaccine.   Vaccine was given.
I had a body-cache after Covid19 vaccine (Moderna). I ate Tylenol pills
Following first dose of COVID-19  vaccine patient complained of an itching  nose  and stated that her "heart is pounding". Patient was taken into a private room to recover.
patient experienced SARS-CoV2 infection; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (patient experienced SARS-CoV2 infection) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jul-2021, the patient experienced COVID-19 (patient experienced SARS-CoV2 infection). At the time of the report, COVID-19 (patient experienced SARS-CoV2 infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medication information was reported. No treatment medications were provided.
pt recv 3 doses of vax & lab eval on 11NOV94 revealed neg anti-HBs,glucose 136,alkaline phos 212,SGOT 43;in f/u pt reported that had lab work done to inc life insurance & that elevated glucose,alkaline phos & SGOT were not b/c vax;
This spontaneous report was received from a medical assistant (clinical coordinator) and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant medications was provided. On an unknown date in 2017, between 27-JUL-2017 and 03-AUG-2017, the patient was vaccinated with improperly stored dose of  VARIVAX injection (lot # reported as N008077; expiration date: 09-MAR-2019; dose and route of administration were not reported). Concomitant therapy included properly stored sterile diluent (MERCK STERILE DILUENT) injection. The reporter stated that the administered dose of VARIVAX was stored at temperature of -10.7 degrees Celsius for 2 hours 10 minutes. Data logger was used to detect temperature excursions. There were no previous temperature excursions reported. No adverse effects were reported. No product quality complaint was involved. This is one of seven reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1708USA005837: US-009507513-1708USA005841: US-009507513-1708USA005839: US-009507513-1708USA005840: US-009507513-1708USA005836: US-009507513-1708USA005838:
A non-serious spontaneous reports of "tested positive for influenza A" has been received from a registered nurse concerning children of unknown age and sex subsequent to H1N1, Intranasal. The patient's medical history and concomitant medications were not reported. The patients received H1N1, Intranasal on 20-Oct-2009. A week after receiving H1N1, Intranasal, on 27-Oct-2009, the patients experienced flu like symptoms and tested positive for influenza A. The patients had fevers of 103 degrees, runny nose, and cough. The outcome of the event was unknown.
THE DOSES WERE ADMINISTERED 2 HOURS PAST RECOMMENDED EXPIRY DATE FOR ROOM TEMPERATURE STORAGE; OUT OF SPECIFICATIONS PRODUCT USE; This spontaneous report received from a health care professional concerned a 63 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 14-JUN-2021 13:26 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 14-JUN-2021, the subject experienced the doses were administered 2 hours past recommended expiry date for room temperature storage. On 14-JUN-2021, the subject experienced out of specifications product use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the the doses were administered 2 hours past recommended expiry date for room temperature storage and out of specifications product use was not reported. This report was non-serious. This case, from the same reporter is linked to 20210632891.
Patient had some redness appear at the site of the injection >24 hours after recieving the vaccine.  Not raised, slightly warm, not hard and not itchy.  Advised the patient to contact her physician as well and to take an antihistamine (i.e. benadryl or claritin).
Flu symptom, achy, 101 fever, headaches, all night first night stabbing pains in gut and legs, fatigue
At approximately 3:21pm, patient developed a small rash on both of the lower halves of her upper arms. RN contacted the PA who agreed the patient should be given diphenhydramine 50mg p.o. She was given the dose and stayed 1/2 hr and then left as she was feeling fine.  Had a similar reaction with the first dose received.  She had already discussed this with her MD and he was fine with her receiving the second dose.  She was driven home by a family member and is feeling fine, when I called her at home.
It was sore with the other ones although not particularly really really sore; This is a spontaneous report received from contactable reporter (Consumer or other non HCP) from medical information team. The reporter is the patient.  An 81-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "It was sore with the other ones although not particularly really really sore".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201142435 same patient/product/event, different dose;US-PFIZER INC-202201142436 same patient/product/event, different dose;US-PFIZER INC-202201142437 same patient/product/event, different dose;
4 weks after vaccination I was foud to have uveitis, initially in the right eye and then in both
Pt and twin brother with neonatal seizure disorder, he was on phenobarbital with seizures controlled (no sz > 1 month prior to vaccines). Got PENTACEL and PREVNAR 11/22/13 and sz began 8 d later. Development has been delayed following increase in sz frequency at that point.
The next day after vaccine, I felt tired. I started getting chills, very nauseous. I then started vomiting. I could not even keep down water. I tried treating at home with Pedialyte and I still kept throwing up. I threw up about 4 more times. I did not have anything to vomit and had dry hives. I ate breakfast the next morning and kept vomiting more. I did a telehealth visit and they said it could be the vaccine. The day after that, I had more vomiting and diarrhea on until the night. This stopped on 1/20/2022 but the weakness continued until 1/22/2022. I also did a follow up with my doctor.
approx 4hrs p/vax pt cried for 40min; vomited large amount of milk then appeared calmer; that evening pt cried for 1/2hr; mod swelling to inj site;
Cause of death to be Parkinson's Disease secondary to ASHD (atherosclerotic heart disease); Atherosclerotic Cardiovascular Disease; This spontaneous case was reported by a nurse and describes the occurrence of PARKINSON'S DISEASE (Cause of death to be Parkinson's Disease secondary to ASHD (atherosclerotic heart disease)) and ARTERIOSCLEROSIS (Atherosclerotic Cardiovascular Disease) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergy to Sinemet).    On 07-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PARKINSON'S DISEASE (Cause of death to be Parkinson's Disease secondary to ASHD (atherosclerotic heart disease)) (seriousness criteria death and medically significant) and ARTERIOSCLEROSIS (Atherosclerotic Cardiovascular Disease) (seriousness criterion death). The patient died on 08-Jul-2021. The reported cause of death was parkinson's disease and Atherosclerotic cardiovascular disease. It is unknown if an autopsy was performed.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient passed away (08Jul2021 at 4:10 PM). The HCP reported that the death certificate showed cause of death to be Parkinson's Disease secondary to ASHD (atherosclerotic heart disease). No concomitant medication details was provided. No treatment medication details was provided.  Very Limited information regarding the events has been provided at this time . Further information has been requested.; Sender's Comments: Very Limited information regarding the events has been provided at this time . Further information has been requested.; Reported Cause(s) of Death: Parkinson's Disease; Atherosclerotic Cardiovascular Disease
Started out with a sore throat, turned into what felt like the full blown flu. Headache, shortness of breath, vomiting, dehydration, dizziness, bodyaches, chills, fever, muscle aches.
Started feeling light headed blood pressure was abnormally high couldn't walk much all occurred a month after vaccine.
RIGHT AND LEFT THIGH WITH REDNESS, LEFT THIGH WITH LARGER AREA OF REDNESS THAN RIGHT THIGH.
Evening of shot pt developed severe pain at injection site (L) deltoid, swelling soft tissue into (L) neck, (L) supraclavicular lymph node, severe (L) trapezius muscle spasm and sensory abnormalities (L) UE.
No adverse event; Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 57-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 25-Feb-2022, the patient received third dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 25-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date).    No concomitant medication was reported.  No treatment medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live non significant Follow up received; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704416:Master case
ON 1/5/21 AT 12:30PM, DEVELOPED HOT FLASHES THAT LASTED 20 MINUTES BEFORE RESOLVING.
Cannot move his right cheek/Bell's palsy/Right side of his face was paralyzed; A spontaneous report was received from a consumer concerning a 67-year old male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced  Bell's palsy.  The patient's medical history was not provided. Concomitant medications were not provided by reporter.  On 06 Mar 2021, 2 days prior to the onset of the events, the patient received the first of the two of their planned doses of mRNA-1273 (Lot number: 029A21A) in the left arm for prophylaxis of COVID-19 infection.   Patient received the vaccine on 06 Mar 2021. On 07 Mar 2021, the patient called to report biting of teeth and hard to swallow. On 08 Mar 2021 upon waking up he noticed he could not move his right cheek. He went to his doctor and an MRI was done of the brain. Doctors impression was Bell's palsy. On 09 Mar 2021, he noted that the right side of his face was paralyzed. He cannot close his right eye; the right side of his mouth was always downwards and his "eyeballs were not on the same level".  The patient was prescribed with prednisone 20mg 3 tabs to be once a day for 7 days, 2 tabs to be taken once a day for 3 days, and 1 tab to be taken once a day for 3 days.  Action taken with mRNA-1273 in response to the event was not applicable.  The event Bell's palsy was deemed medically significant.   The outcome of the events Bell's palsy was not recovered/resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Received 2nd varicella on 8/7/07. Within a few minutes of receiving the vaccine, vaccine site started swelling. Two nights after receiving the vaccine the injection site has started itching. Injection site is now really hot and the area is soft blue. Advised mother to have child arm evaluated by doctor today.
Noticed slight burning and tingling in arm during vaccine administration.  Approximately 30 minutes later burning had subsided but had tingling L elbow, pain fingers L hand (esp. little finger), and pain if clenching fist (these symptoms did not subside).  Seen same day @ 1530 by MD at same office immunization given. Advised to return if symptoms worsen or do not resolve.
approx 4yrs p/vax pt devel chickenpox rash consisting of over 100 lesions. rash was maculopapular. addl info requested
High fever (up to 104 degrees F) for 3 days, gave constant fever reducers (ibuprofen, acetaminophen), resolved on 4th day.
it was administered after the temp excursion had occurred.; This spontaneous report was received from a medical assistant referring to a patient of unknown age. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not reported.   On 29-DEC-2020, the patient was vaccinated with an improperly stored dose of  rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot #S040076, expiration date 15-JUN-2021, orally for prophylaxis (dose and vaccination scheme frequency were not reported).   The vaccine was stored in a temperature of 22.7 degree Fahrenheit (F) for 35 minutes on 22-DEC-2020, as recorded by a data logger. There was a previous temperature excursion of 32.6F for 30 minutes on 07-DEC-2020.
30MAR92 pt recvd vax & was given APAP p/returning home-sponged-fever 101; 31MAR92 ER w/fever t104 R skin fiery red, fusy crying; raised, bruised area on leg; mom states gave APAP a 4 hrs & sponged 3 days;
Body aches (approximately 36-40 hours), low grade fever (under 100 degrees) & chills (approximately 36-40 hours). This am feeling back to normal.
Swollen lymph nodes under left arm, chest, collarbone approximately 12 hours after vaccine received. Aches overall and low fever (under 101)
Moderna COVID-19 Vaccine EUA.  Pain in injection site going up my arm into my neck, jaw and head. This started right away and I still have this issue. Dizziness, rash at injection site, heart flutters, swelling at injection site, fever, chills, bad muscle aches all over, joint pains, some nausea  - all these lasted about 3 1/2 days.
Symptoms:  Intractable Vomiting, felt hot/cold, temperature 100 F, fatigue "wiped out" and pain at the injection site. Time Course: low grade fever and vomiting 36 hours, soreness at injection site and fatigue continued. Treatment: clear liquids, white soda and soda crackers.
erythema multiforme rash on 18APR98 w/thrombocytopenia, fever;dx measles thrombocytopenia w/viral infect;
Within three days of shot started with blurred vision, swerving while driving,  progressing rapidly to unable to hold fork, falling down.  Hospitalized since.  Lost all motor skills, unable to walk, stand, feed self, control urine, slurring speech.  No stroke.  MRI found "lesions" in brain, spine/neck area, lung and stomach.  Four Neurologists examined.  They still are perplexed.  One said she has not seen anything like this in her 20 years. Spent week in hospital, now in rehab center Minor improvement in ability to feed self (still can not hold fork),  Receiving physical therapy.
This spontaneous report as received from a consumer, who is a patient of a physician, refers to another patient of unknown age and gender. On an unknown date the separate patient was vaccinated with ZOSTAVAX (dose, route, lot # unknown). On an unknown date, the patient experienced bells palsy after receiving ZOSTAVAX. The outcome of the event was unknown. Additional information is not expected.
Patient contracted COVID after  being fully vaccinated.  No Booster. Asymptomatic exposure.
LOCALISED DISCOMFORT; MUSCULAR BURNING SENSATION; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A expiry: UNKNOWN) dose was not reported, administered on 29-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient experienced localised discomfort, and muscular burning sensation. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the muscular burning sensation and localised discomfort was not reported. This report was non-serious. This case, from the same reporter is linked to 20220260749.
No adverse effects reported; Multiple patients were vaccinated with improperly stored VAQTA; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's concurrent conditions and medical history, as well as concomitant medications, were not reported.  On 21-JUN-2019, the patient was vaccinated with an improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) 25/0.5 (units not provided), lot # R018935, expiration date 05-SEP-2019, for prophylaxis (dose, route, anatomical site and frequency were not reported). The reporter stated that the vaccine had a temperature excursion of 34.2 F for 4 hours and 54 minutes, which was detected by a data logger. The vaccine had no previous temperature excursion and there were no adverse effects reported.  This is one of several cases from the same reporter.; Sender's Comments:  US-009507513-1907USA001174: US-009507513-1907USA004852: US-009507513-1907USA004853: US-009507513-1907USA004854: US-009507513-1907USA004855: US-009507513-1907USA004856: US-009507513-1907USA004857: US-009507513-1907USA004858: US-009507513-1907USA004859: US-009507513-1907USA004860: US-009507513-1907USA004861: US-009507513-1907USA004862: US-009507513-1907USA004863: US-009507513-1907USA004864: US-009507513-1907USA004865: US-009507513-1907USA004866: US-009507513-1907USA004867: US-009507513-1907USA004868: US-009507513-1907USA004869: US-009507513-1907USA004870: US-009507513-1907USA004871: US-009507513-1907USA004872: US-009507513-1907USA004873: US-009507513-1907USA004874: US-009507513-1907USA004875: US-009507513-1907USA004876: US-009507513-1907USA004877: US-009507513-1907USA004878: US-009507513-1907USA004879: US-009507513-1907USA004880: US-009507513-1907USA004881: US-009507513-1907USA004882: US-009507513-1907USA004884: US-009507513-1907USA004885: US-009507513-1907USA004886: US-009507513-1907USA004887: US-009507513-1907USA004888: US-009507513-1907USA004889: US-009507513-1907USA004890:
p/vax pt exp knot rt leg; it was like ``boil'' now coming to head; area on rt thigh appeared red & bruised;MD did lance & obtained brown fluid; MD stated cause was from dirty needle; react was @ inj site
22DEC 6Pm sz in bath tub taken to hosp in ambulance t104.5; kept overnoc for observation; 30DEC93 sz-ambulance took to ER t104.5; spinal tap neg; blood working; hosp x 3 days rash 31DEC93;